Sotabase

Career

· AI/ML Research Intern, Berkeley Artificial Intelligence Research (BAIR)2023–
· Intern, Salesforce2023–2023
· Project Manager, DataStory at Berkeley2022–
· Research Assistant, UC Berkeley AUTOLab2022–
· Graduate Student, University of California, Berkeley2021–

Publications (171)

Medical Applications and Toxicities of Gallium Compounds
International Journal of Environmental Research and Public Health · 2010
334
cited
Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
New England Journal of Medicine · 1990
256
cited
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.
JAMA Oncology · 2020
255
cited
Transferrin Receptor-dependent Iron Uptake Is Responsible for Doxorubicin-mediated Apoptosis in Endothelial Cells
Journal of Biological Chemistry · 2002
220
cited
Gallium and its competing roles with iron in biological systems.
Biochimica et Biophysica Acta · 2016
212
cited
Gallium-containing anticancer compounds.
Future Medicinal Chemistry · 2012
171
cited
Oxidative Stress–Induced Iron Signaling Is Responsible for Peroxide-Dependent Oxidation of Dichlorodihydrofluorescein in Endothelial Cells: Role of Transferrin Receptor–Dependent Iron Uptake in Apoptosis
Circulation Research · 2003
154
cited
Effects of different transferrin forms on transferrin receptor expression, iron uptake, and cellular proliferation of human leukemic HL60 cells. Mechanisms responsible for the specific cytotoxicity of transferrin-gallium.
Journal of Clinical Investigation · 1986
136
cited
Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation. Effects of gallium and dimethylsulfoxide.
Journal of Clinical Investigation · 1983
127
cited
Uptake of gallium-67 by human leukemic cells: demonstration of transferrin receptor-dependent and transferrin-independent mechanisms.
Cancer Research · 1987
119
cited
Inhibition of leukemic HL60 cell growth by transferrin-gallium: effects on ribonucleotide reductase and demonstration of drug synergy with hydroxyurea [see comments]
1988
110
cited
The therapeutic potential of iron‐targeting gallium compounds in human disease: From basic research to clinical application
Pharmacological Research · 2017
101
cited
Nitric oxide inhibits H2O2-induced transferrin receptor-dependent apoptosis in endothelial cells: Role of ubiquitin-proteasome pathway
Proceedings of the National Academy of Sciences of the United States of America · 2003
98
cited
Development of Gallium Compounds for Treatment of Lymphoma: Gallium Maltolate, a Novel Hydroxypyrone Gallium Compound, Induces Apoptosis and Circumvents Lymphoma Cell Resistance to Gallium Nitrate
Journal of Pharmacology and Experimental Therapeutics · 2007
97
cited
Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells.
Experimental Hematology · 1995
95
cited
Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells.
Cancer Research · 1991
94
cited
Inhibition of malignant cell growth by 311, a novel iron chelator of the pyridoxal isonicotinoyl hydrazone class: effect on the R2 subunit of ribonucleotide reductase.
Clinical Cancer Research · 2001
88
cited
Effect of gallium on the tyrosyl radical of the iron-dependent M2 subunit of ribonucleotide reductase.
Biochemical Pharmacology · 1992
73
cited
Continuous 5‐Fluorouracil (5FU) Infusion in Carcinoma of the Pancreas: A Phase II Study
American Journal of the Medical Sciences · 1988
71
cited
Continuous 5‐Fluorouracil Infusion in Advanced Gastric Carcinoma
American Journal of Clinical Oncology · 1988
69
cited
Sotabase